STEPHAN DIETRICH A (President and CEO) purchased 95.8% of their position (12K shares) of NEUBASE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $60.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/27/2021ACC: 0001104659-21-055581
DirectorOfficer· President and CEO
Since Jul 2019
+12K
Net shares
Net buyer
$60.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
12K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12K
Price / share
$5.00
Trade value
$60K
% of position
95.8%
4/26/2021
12.53K→24.52K
Total
Net shares
+12K
Net value
$60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/26/2021 | P · Purchase | +12K | $5.00 | $60K | 95.8% | 12.53K | 24.52K |
| Total | +12K | $60K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.27M
Total
1.27M indirect1.27M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.27M | Indirect |
| Total | 1.27M | 1.27M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported